Boyd Ben J
Department of Pharmaceutics, Victorian College of Pharmacy - Monash University, 381 Royal Pde, Parkville, VIC, 3052, Australia.
Expert Opin Drug Deliv. 2008 Jan;5(1):69-85. doi: 10.1517/17425247.5.1.69.
Colloidal drug delivery systems have been providing alternative formulation approaches for problematic drug candidates, and improved delivery for existing compounds for decades. Colloidal systems for drug delivery have all evolved down a similar pathway, almost irrespective of the delivery system, from conception, to the use of safer excipients, PEGylation for passive targeting and attachment of ligands for active targeting. The recent emergence of truly biologically interactive systems represents the latest step forward in colloidal delivery systems. In this article, the maturation pathway and recent advances for the major classes of colloidal delivery systems are reviewed, and the paper poses the question of whether the nanotechnology boom will create a revolution in colloidal delivery, or just the next natural stage in evolution.
几十年来,胶体药物递送系统一直为有问题的候选药物提供替代的制剂方法,并改善现有化合物的递送。几乎不管递送系统如何,用于药物递送的胶体系统都沿着相似的路径发展,从概念构思,到使用更安全的辅料、用于被动靶向的聚乙二醇化以及用于主动靶向的配体附着。真正具有生物相互作用的系统的近期出现代表了胶体递送系统向前迈出的最新一步。在本文中,综述了主要类型的胶体递送系统的成熟路径和近期进展,并且本文提出了纳米技术热潮是否会在胶体递送方面引发一场革命,或者仅仅是进化过程中的下一个自然阶段这一问题。